LAM is caused by mutations in the tuberous sclerosis genes, resulting in activation of the mammalian target of the rapamycin complex 1 (mTORC1) signalling network [4], a protein kinase that controls cell growth, proliferation and survival, and contributes to the uncontrolled proliferation of LAM cells [5]. Here, WEE1 is linked to lymphangioleiomyomatosis.